Hotline:+86 2884841969
Outbound Sales&Marketing

Ms.Yang 
Tel: +86 2884841969 
Mobile: +86 13876200465 (English) 
Skype/Wechat:+86 13876200465 
Email: ycling@enlaibio.com

Mr. Yang  
Tel: +86 2884871826
Mobile: +86 13908183771   
Email: yangcx@enlaibio.com
Industry News Your current location:Homepage >Industry News
请添加图片
First line treatment for chronic lymphocytic leukemia

As a first line treatment drugs for chronic lymphocytic leukemia, Ibrutinib improves survival compared with Ofatumumab in patients with previously treated Chronic Lymphocytic Leukemia.

From Poverty to Harvard Postdoc2013-10-24

Fingerprints Expose Chemical Identities 2019-01-04

2019 CPHI Shanghai Bio-Pharm Expo 2019-08-18